Calvin Sandra

Travere Therapeutics, Inc. ยท SVP

Calvin Sandra is listed in public filings as officer: SVP, CHIEF ACCOUNTING OFFICER. This Calvin Sandra insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Travere Therapeutics, Inc. (TVTX). Investors use Calvin Sandra's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Travere Therapeutics, Inc.TVTX$1.7M42.4k sharesSellApr 14, 2026$902.6K22k shares$41.07--
Travere Therapeutics, Inc.TVTX$399k19.5k sharesGrant / ExerciseApr 14, 2026$133.0K6.5k shares$20.46--
Travere Therapeutics, Inc.TVTX$112k5k sharesGrant / ExerciseApr 14, 2026$56.0K2.5k shares$22.40--
Travere Therapeutics, Inc.TVTX$112k12.5k sharesGrant / ExerciseApr 14, 2026$55.8K6.3k shares$8.93--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Travere Therapeutics, Inc.TVTX$1.6M49.1k sharesSellFeb 3, 2026$139.2K4.3k shares$32.12--
Travere Therapeutics, Inc.TVTX$667k20.2k sharesGrant / ExerciseJan 31, 2026$667.2K20.2k shares$33.10--
Travere Therapeutics, Inc.TVTX--53.4k sharesGrant / ExerciseJan 31, 2026Disclosure amount unavailable15.2k shares----
Travere Therapeutics, Inc.TVTX$1.5M38.2k sharesSellDec 24, 2025$296.1K7.4k shares$40.00--
Travere Therapeutics, Inc.TVTX$1.6M45.6k sharesSellDec 15, 2025$104.8K2.9k shares$36.00--
Travere Therapeutics, Inc.TVTX$1.7M48.5k sharesSellNov 4, 2025$2.4M67.1k shares$36.00--
Travere Therapeutics, Inc.TVTX$017.5k sharesGrant / ExerciseNov 4, 2025$470.4K17.5k shares$26.88--
Travere Therapeutics, Inc.TVTX$69k2.5k sharesGrant / ExerciseNov 4, 2025$412.5K15k shares$27.50--
Travere Therapeutics, Inc.TVTX$168k7.5k sharesGrant / ExerciseNov 4, 2025$280.0K12.5k shares$22.40--
Travere Therapeutics, Inc.TVTX$010k sharesGrant / ExerciseNov 4, 2025$252.5K10k shares$25.25--
Travere Therapeutics, Inc.TVTX$167k18.8k sharesGrant / ExerciseNov 4, 2025$55.8K6.3k shares$8.93--
Travere Therapeutics, Inc.TVTX$1.6M63.7k sharesSellFeb 11, 2025$375.0K15k shares$25.00--
Travere Therapeutics, Inc.TVTX$015k sharesGrant / ExerciseFeb 11, 2025$231.9K15k shares$15.46--
Travere Therapeutics, Inc.TVTX$1.4M54.4k sharesSellFeb 11, 2025$231.1K9.2k shares$25.00--
Travere Therapeutics, Inc.TVTX$010k sharesGrant / ExerciseFeb 11, 2025$179.6K10k shares$17.96--
Travere Therapeutics, Inc.TVTX$010k sharesGrant / ExerciseFeb 11, 2025$174.4K10k shares$17.44--
Travere Therapeutics, Inc.TVTX$010k sharesGrant / ExerciseFeb 11, 2025$162.3K10k shares$16.23--
Travere Therapeutics, Inc.TVTX$1.3M63.7k sharesSellFeb 3, 2025$67.4K3.3k shares$20.12--
Travere Therapeutics, Inc.TVTX$532k26k sharesGrant / ExerciseJan 31, 2025$532.0K26k shares$20.46--
Travere Therapeutics, Inc.TVTX--67k sharesGrant / ExerciseJan 31, 2025Disclosure amount unavailable13k shares----